Senior insider sale
Chief Development Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$40.1K
4.66K shares
What this filing means
SEE TAI SANDI plans to sell 4.66K shares of LEXEO THERAPEUTICS, INC. valued at approximately $40.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/18/2025ACC: 0001959173-25-007113
Officer· Chief Development Officer
Since Feb 2024
4.66K
Shares to sell
$40.1K
Approx. market value
386.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
11/17/2025
386.00Total acquired386.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/17/2025 | Restricted Stock Vesting Compensation | 386.00 | — |
| Total | 386.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.89K
Market value
$34.8K
10/17/2025
—Completed
Units to sell
382.00
Market value
$1.8K
8/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
386.00
Market value
$3.6K
11/18/2025
Total
Units
4.66K
Value
$40.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/17/2025 | 3.89K | $34.8K | — | Completed |
8/18/2025 | 382.00 | $1.8K | — | Completed |
| Planned — Approximate Date | ||||
11/18/2025 | 386.00 | $3.6K | NASDAQ | Planned |
| Total | 4.66K | $40.1K | ||